Activation of stress-activated protein kinases, including the p38 and the c-Jun NH 2 -terminal kinases (JNK), have been associated with the onset of cardiac hypertrophy and cell death in response to hemodynamic overload and ischemia/reperfusion injury. Upon infection of cultured neonatal rat cardiac myocytes with recombinant adenoviral vectors expressing a wild type and a constitutively active mutant of MKK7 (or JNKK2), JNK was specifically activated without affecting other mitogen-activated protein kinases, including extracellular signal-regulated protein kinases and p38. Specific activation of the JNK pathway in cardiac myocytes induced characteristic features of hypertrophy, including an increase in cell size, elevated expression of atrial natriuretic factor, and induction of sarcomere organization. In contrast, co-activation of both JNK (by MKK7) and p38 (by MKK3 or MKK6) in cardiomyocytes led to an induction of cytopathic responses and suppression of hypertrophic responses. These data provide the first direct evidence that activation of JNK alone is sufficient to induce characteristic features of cardiac hypertrophy, thereby supporting an active role for the JNK pathway in the development of cardiac hypertrophy. The cytopathic response, as a result of co-activation of both JNK and p38, may contribute to the loss of contractile function and viability of cardiomyocytes following hemodynamic overload and cardiac ischemia/reperfusion injury.
Cardiac hypertrophy and heart failure are multi-step pathophysiological processes involving extracellular stimuli, such as mechanical stress, cytokines and growth factors, and intracellular signaling pathways, including mitogen-activated protein (MAP) 1 kinase pathways (1) (2) (3) (4) (5) . The MAP kinase signaling pathways consist of three major phosphorylation cascades, i.e. the extracellular signal-regulated protein kinases (ERK), the c-Jun NH 2 -terminal kinases (JNK), and the p38 MAP kinases (6, 7) . JNK and p38 pathways are collectively termed stressactivated protein kinases because they are activated by various stress-related stimuli (8) . It has been shown that p38 MAP kinase activity is activated in hypertrophied 2 and ischemic hearts (10, 11) . In neonatal cardiomyocytes, activation of the p38 pathway by an upstream activator MKK6 induces characteristic features of hypertrophy (12, 13) . In contrast, activation of p38 activity by another upstream activator, MKK3, gives rise to the mixed responses of hypertrophy and apoptosis, possibly mediated by different p38 isoforms (12) . These studies support the hypothesis that p38 may mediate the hypertrophic process in vivo and contribute to the myocyte apoptosis that is observed in post-ischemic hearts as well as end stage failing hearts (14) .
JNK is the first MAP kinase that is activated in mouse heart by pressure-overload, 3 and is also activated in Ras induced hypertrophied transgenic hearts (15) . JNK activation is also associated with ischemia/reperfusion (10, 11) . It can be induced by an ␣-adrenergic agonist, phenylephrine (PE), and is required for the induction of atrial natriuretic factor (ANF) promoter activity by PE in cardiac myocytes (15) . In a separate study, activated MEKK-1, an upstream activator of JNK, has been shown to be able to activate some of the characteristic features of hypertrophy in neonatal cardiomyocytes (13) . However, because PE treatment and the activated MEKK-1 also activate other MAP kinases, including ERK and p38, the specific function of JNK in cardiac hypertrophy is still not yet clear. Recently, several groups have reported the cloning of a new MAP kinase kinase, MKK7 (also named JNKK-2), which is able to specifically activate the JNK pathway without affecting ERK and p38 activities (16 -18) . 4 In this study, we examine the effects of MKK7-mediated JNK activation on neonatal cardiac myocytes. Our results show that specific activation of the JNK pathway in cardiac myocytes is sufficient to induce characteristic features of hypertrophy. Furthermore, co-activation of JNK and p38 pathways in cardiac myocytes leads to cytopathic responses in cardiac myocytes and induction of cell death. These results support the hypothesis that both JNK and p38 play pivotal roles in the development of cardiac hypertrophy and that combined effects of JNK and p38 may contribute to the pathophysiological process of heart failure.
EXPERIMENTAL PROCEDURES
Culture of Neonatal Rat Cardiac Myocytes-Ventricular myocytes from 1-2-day-old Sprague-Dawley rats were prepared using a Percoll gradient method as described previously (19) . The cells were plated in serum containing media (4:1 Dulbecco's modified Eagle's medium: medium 199, 10% horse serum, 5% fetal bovine serum, 100 units/ml penicillin, 100 mg/ml streptomycin, and 10 mM glutamine) overnight and changed into serum-free media when they were infected with adenoviruses at a multiplicity of infection of 50 -100 particles/cell for 16 h. The cells were then cultured for an additional 36 h before morphological or biochemical analysis.
Molecular Cloning of Human MKK7 cDNA--Degenerated oligonucleotides, ATHATHGCNGTNAARCAR and TTNACRTCNCKRTGDAT, that correspond to the conserved kinase subdomain II and VI of Drosophila MAPKK hep were used to amplify a MAPKK-specific cDNA fragment from first-strand cDNA synthesized with HeLa cell poly(A) ϩ mRNA by polymerase chain reaction. One DNA sequence from the polymerase chain reaction product was found to be homologous to both hep and human JNKK1. This DNA fragment was used to screen a human B-cell library (Invitrogen). The full-length MKK7 cDNA was constructed from a cDNA clone with the longest coding sequence and a cDNA clone from the expressed sequence tag gene bank (accession number H85962) that has overlapping sequences.
Recombinant Adenovirus Vectors-Recombinant adenoviruses expressing green fluorescent protein (Adv/GFP) and activated mutants of MKK6 and MKK3 (Adv/MKK6bE and Adv/MKK3bE) have been described elsewhere (12, 20) . Recombinant adenoviruses expressing wild type and activated mutant (Ser 271 and Thr 275 to Asp) of human MKK7 gene were generated by homologous recombination between the plasmid pJM17 and shuttle plasmids with MKK7 cDNAs cloned into the HindIII and XbaI sites of the pAdv/RSV vector (20) . The concentrated recombinant adenoviruses were prepared and titered as described (21) .
MAP Kinase Assays-Protein extracts from myocytes were prepared and assayed for kinase activities as described previously (12) . The MAP kinases were immunoprecipitated using rabbit polyclonal anti-JNK1, -p38, or -ERK1 antibodies (Santa Cruz Biotechnology, Inc.) conjugated to protein A-Sepharose. The kinase assays were performed at 30°C using [␥-32 P]ATP and myelin basic protein (Sigma) as a substrate for ERK1 and p38 or using GST-c-Jun (1-79) as a substrate for JNK. The phosphorylated substrate was separated by SDS-polyacrylamide gel electrophoresis and visualized by autoradiography. The incorporated 32 P i in the substrate was quantified by radioanalytic scanning (AMBIS).
Immunohistochemical Assay-Immunohistochemical analysis of adenovirus-infected cardiac myocytes were performed as described (12) . The expression of the ANF protein was detected using rabbit anti-rat ␣-ANF polyclonal antibody (Peninsula) and fluorescein isothiocyanateconjugated goat anti-rabbit secondary antibody (Amersham). The sarcomere structure was detected using rhodamine-conjugated phalloidin (Sigma).
RESULTS

Specific Activation of JNK by MKK7 in Cardiac
Myocytes-To study the specific function of the JNK pathway in cultured cardiac myocytes, recombinant adenoviruses expressing wild type (Adv/MKK7wt) or activated mutant of MKK7 (Adv/MKK7D) were generated as described under "Experimental Procedures." Approximately 5 ϫ 10 5 rat neonatal cardiac myocytes were infected with 2.5-5 ϫ 10 7 viral particles of different vectors as described. In our previous study, it has been shown that at this dosage, more than 95% of the cardiac myocytes are infected by the adenoviral vector and express the transgene product (12) . MAP kinase activities were measured from cells 48 h after infection. As shown in Fig. 1 , JNK activity was significantly activated up to 4-fold in cells infected with Adv/MKK7wt and Adv/MKK7D but remained at basal levels in cells that were treated with a control Adv vector expressing GFP (control). In contrast, the ERK and the p38 basal level activities were not significantly altered (Fig. 1b) . These data indicate that either wild type or activated MKK7 functions as a JNK-specific activator in cardiac myocytes in the same fashion as demonstrated in other cell types (16 -18) . 4 
MKK7 Induces Characteristic Features of Hypertrophy in
Cardiac Myocytes-To characterize the functional effects of JNK activation on cardiac myocytes, we examined the morphological and biochemical features of the muscle cells that were infected with Adv/MKK7wt and Adv/MKK7D in comparison with untreated cells or cells treated with a control vector. Overexpression of a wild type or an activated mutant of the MKK7 resulted in a hypertrophic change in morphology (Fig.  2a) and a significant increase in cell size (Fig. 2b) . By immunohistochemical analysis using antibodies specifically against ANF protein, we demonstrated that this hypertrophic marker gene was significantly induced in almost all cardiac myocytes that were infected with Adv/MKK7wt or Adv/MKK7D (f and h in Fig. 3 ) but not in untreated myocytes or cells that were infected with a control Adv/GFP vector (b and d in Fig. 3) . Finally, we have also analyzed the cytoskeletal organization in cardiac myocytes by phalloidin staining. As shown in Fig. 3 , expression of MKK7 significantly induced the organization of sarcomere structure (e and g in Fig. 3 ) as compared with untreated cells and cells infected with the control vector (a and c in Fig. 3 ). These data clearly demonstrated that specific activation of the JNK pathway by MKK7 can induce characteristic features of cardiac hypertrophy in cultured myocytes. 
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Cytopathic Response and Cell Death Induced by Co-activation of the JNK and p38
Pathways-JNK appears to be coactivated with p38 in vivo under different physiological stresses, such as pressure-overload 3 and ischemia/reperfusion (10, 11). They are also co-activated in transgenic mouse hearts expressing activated Ras (15) . 2 To characterize the combined effects of both JNK and p38 pathways, upstream activators for both JNK and p38 pathways were co-expressed in cardiac muscle cells. In our previous study (12) , it has been demonstrated that overexpression of a p38-specific activator, MKK6bE, is able to induce significant hypertrophy, whereas overexpression of MKK3bE, another p38-specific activator, induced mixed responses of hypertrophy and apoptosis (a and c of Fig. 4) . When MKK6bE and MKK7D were co-expressed in cardiac myocytes, however, the hypertrophic response observed in either MKK6bE-or MKK7D-expressing cells was significantly inhib- 
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ited (d of Fig. 4) . The cells displayed a cytopathic phenotype characterized by the appearance of many vacuoles in the cytoplasm before death. Overexpression of MKK7D and MKK3bE also induce significant cell death and cytopathic responses in the living cells (e of Fig. 4 ). These data suggest that co-activation of JNK and p38 pathways resulted in the induction of a cytopathic response and cell death.
DISCUSSION
In this report, we have analyzed the direct effects of JNK activation in cardiac myocytes by overexpressing a specific upstream activator, MKK7 using recombinant adenovirus-mediated gene transfer. We have shown that wild type and activated MKK7 specifically activate JNK activity without affecting ERK and p38 activities. Specific activation of JNK in cardiac myocytes induced a hypertrophic response characterized by an increase in cell size, the induction of ANF expression, and enhanced organization of sarcomere structure. This result suggests that specific activation of JNK is sufficient to initiate a hypertrophic response in cardiomyocytes. However, we cannot rule out the involvement of p38 in such a response because there are still significant p38 basal level activities in the cultured cardiac myocytes (Fig. 1) . Co-activation of JNK and p38 in cardiac myocytes, however, failed to synergize in their hypertrophic effects. Instead, this led to induction of cytopathic responses and cell death.
JNK activity is quickly activated by pressure-overload in transverse aortic constriction treated animals followed by activation of p38 at a later time point. 3 Combined with the results from this study, a model can be hypothesized where the activation of JNK may contribute directly to the development of hypertrophy at the earlier time points of pressure overload. In the setting of long term hemodynamic stress, both JNK and p38 activities are activated that lead to dysfunction and death of the myocytes. This hypothesis needs to be tested in vivo by creating transgenic animals with altered stress-activated protein kinases activities in heart and studying their effects on cardiac functions using miniaturized physiological technology (9) .
